Department of Pharmaceutics
| Identified Thrust Areas | Sub-Areas |
| Development of modified and site specific drug delivery systems |
Novel Dosage forms for Oral Cavity Organ Targeted Delivery for Various Diseases |
| Formulation and characterisation of micro/ nanocarrierbased drug delivery systems |
Oral/ Parenteral/ Topical/ Ocular Novel Formulations using QBD Approach |
| Dissolution/ Bioavailability enhancementof poorly soluble APIs |
Colloidal and Nanoparticulate System |
Department of Pharmaceutical Chemistry
| Identified Thrust Areas | Sub-Areas |
| Conventional and Solid / Liquid phase combinatorial synthesis including microwave assisted synthesis of potentially useful novel chemical entities for various disorders | Solid Tumors, Lymphoma, Melanoma, Leukemia, etc Diabetes and Obesity Cardiovascular Diseases like Hypertension, Hyperlipidemia, etc Inflammatory Disorders and Allergy Infectious Diseases Including HIV, Tb, Malaria, etc |
| Drug design of NCEs using various in silico methods | PharmacophoreModeling Virtual Screening QSAR Molecular Docking Homology Modeling MD Simulation Studies In Silico ADMET Predictions |
Department of Pharmaceutical Analysis
| Identified Thrust Areas | Sub-Areas |
| Development and validation of anlytical methods | Stability indicating assay methods for APIs and formulations Dissolution method development and validation for different types of dosage forms Development and validation of bioanalytical methods for biological fluids Application of Quality by Design approach in analytical method development |
| Solid state analysis by spectroscopic methods like FTIR, Raman Spectrometer etc Standardization of polyherbal formulation Isolation and identification of biomarkers from plants and herbal formulations |
Super critical fluid extraction and quantification of phyto constituents. |
Department of Pharmacognosy
| Identified Thrust Areas | Sub-Areas |
| Phytopharmacological Evaluation of Herbal Drugs and characterisation of bioactives for various diseases |
Neurodegenerative disorders, Cancer, Wound healing, Diabetes, Obesity, Urolithiasis |
| Formulation, Development and evaluation of Nutraceuticals and Herbal Cosmetics | Herbal formulations Nutritional supplements Hair care cosmetics products Skin care cosmetic products |
| Formulation of nanotechnological based products for targeted delivery of natural bioactives |
Novel approaches like Polymeric nanoparticles for targeted brain delivery |
| Isolation, estimation and characterization of phyto-constituents | Isolation of various secondary metabolites from plants Separation estimation of phytoconstituents by various spectroscopy and chromatography techniques |
| Quality control & standardization of natural products and herbal formulations |
Development of plant monograph Standardization of herbal drugs Standardization of formulations |
| Development of analytical method and its validation of active phyto- constituents from natural products using various sophisticated instruments |
Estimation of phytoconstituents by HPLC and HPTLC |
Department of Pharmacology
| Identified Thrust Areas | Sub-Areas |
| Identification of novel therapeutic targets, development of novel experimental models and pharmacological evaluation | Neurodegenerative, psychiatric and cerebrovascular disorders Cancer and cachexia Endocrine and metabolic disorders Cardiovascular diseases Gastrointestinal disorders Ophthalmic disorders Inflammation and allergy |
| Safety Pharmacology, Pharmacokinetics, Toxicokinetics and Toxicity Studies | New Chemical Entities Novel formulations Medical devices Phytoconstituents Herbal extracts and formulations |
| Formulation development, characterisation and biological evaluation for novel targeted drug delivery systems |
In-vitro studies, Ex-vivo studies, In-vivo studies, In Vitro- InVivo Correlation , PK-PD studies |
| Clinical Research | Clinical trials Epidemiological studies Meta-analysis BA/BE studies Pharmacovigilance |
